MODERNA BIOTECHNOLOGY

EUIPO EUIPO 2020 Trademark registered

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark MODERNA BIOTECHNOLOGY was filed as Word mark on 05/19/2020 at the European Union Intellectual Property Office.
It was registered as a trademark on 09/23/2020. The current status of the mark is "Trademark registered".

Trademark Details Last update: May 16, 2024

Trademark form Word mark
File reference 018241405
Application date May 19, 2020
Publication date June 16, 2020
Entry date September 23, 2020
Expiration date May 19, 2030

Trademark owner

325 Binney Street
02142 Cambridge
US

Trademark representatives

C/ VALLE DE LACIANA 65 28034 MADRID ES

goods and services

1 Biochemicals, namely, protein-encoding nucleic acids and polypeptide-encoding nucleic acids for use in the manufacture of pharmaceuticals for treating cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious disorders, and reproductive disorders; reagents for testing sterility of pharmaceuticals; diagnostic reagents for scientific or research use; chemicals for use in biotherapeutics, biosimilars and therapeutics product development and manufacturing processes; polypeptide encoding nucleic acids for laboratory use
5 Medical, biological and pharmaceutical preparations for scientific, research, medical, or pharmaceutical use, namely, preparations for treating cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious disorders, and reproductive disorders; medical, biological and pharmaceutical preparations containing polypeptide encoding nucleic acids for the prevention and treatment of rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious disorders and reproductive disorders; RNA-based therapeutics and therapeutic agents for in vitro preparation and in vivo, ex vivo, or on vivo delivery to cell sites; medical diagnostic reagents; a full line of pharmaceuticals, vaccines, medicines, biologics, biotherapeutics, biosimilars and therapeutics
42 Scientific research in the fields of pharmaceuticals, vaccines, medicine, biologics, biotherapeutics, biosimilars and therapeutics; design, engineering, research, development and testing services in the field of protein-encoding nucleic acids and polypeptide-encoding nucleic acids

Trademark history

Date Document number Area Entry
May 15, 2024 Transfer / Change of address, Published
August 15, 2023 Change Representative, Published

ID: 11018241405